Intra-Cellular Therapies Inc
NASDAQ:ITCI

Watchlist Manager
Intra-Cellular Therapies Inc Logo
Intra-Cellular Therapies Inc
NASDAQ:ITCI
Watchlist
Price: 131.87 USD -0.04% Market Closed
Market Cap: 14B USD

Intrinsic Value

The intrinsic value of one ITCI stock under the Base Case scenario is 90.4 USD. Compared to the current market price of 131.87 USD, Intra-Cellular Therapies Inc is Overvalued by 31%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ITCI Intrinsic Value
90.4 USD
Overvaluation 31%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Intra-Cellular Therapies Inc

ITCI
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for ITCI cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Intra-Cellular Therapies Inc
NASDAQ:ITCI
US
Pharmaceuticals
Market Cap
14B USD
IPO
Jan 31, 2014
US
Pharmaceuticals
Market Cap
14B USD
IPO
Jan 31, 2014
Price
$false
EPS
$false
Company Overview
Loading...
Business Segments
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
Bear Theses

Heightened reliance on CAPLYTA leaves the firm vulnerable if commercial uptake underperforms — with almost all revenues riding on a single product, any shift in physician prescribing habits or unexpected regulatory snags could sharply impact top-line results.

Bull Theses

CAPLYTA’s strong efficacy-benign side effect profile in schizophrenia and bipolar depression positions it as a potential best-in-class therapy — positive feedback from both patients and clinicians could accelerate market adoption and boost revenue growth.

Show More Less
How do you feel about ITCI?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Intra-Cellular Therapies Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Intra-Cellular Therapies Inc

Current Assets 1.3B
Cash & Short-Term Investments 1B
Receivables 166.5m
Other Current Assets 139.8m
Non-Current Assets 59.5m
PP&E 14.9m
Other Non-Current Assets 44.7m
Efficiency

Free Cash Flow Analysis
Intra-Cellular Therapies Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Intra-Cellular Therapies Inc

Revenue
680.9m USD
Cost of Revenue
-57m USD
Gross Profit
623.9m USD
Operating Expenses
-740.6m USD
Operating Income
-116.7m USD
Other Expenses
42m USD
Net Income
-74.7m USD
Fundamental Scores

ITCI Profitability Score
Profitability Due Diligence

Intra-Cellular Therapies Inc's profitability score is 38/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Years Revenue Growth
Positive Gross Profit
Exceptional Revenue Growth Forecast
ROE is Increasing
38/100
Profitability
Score

Intra-Cellular Therapies Inc's profitability score is 38/100. The higher the profitability score, the more profitable the company is.

ITCI Solvency Score
Solvency Due Diligence

Intra-Cellular Therapies Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
81/100
Solvency
Score

Intra-Cellular Therapies Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ITCI Price Targets Summary
Intra-Cellular Therapies Inc

Wall Street analysts forecast ITCI stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ITCI is 133.21 USD with a low forecast of 119.18 USD and a high forecast of 138.6 USD.

Lowest
Price Target
119.18 USD
10% Downside
Average
Price Target
133.21 USD
1% Upside
Highest
Price Target
138.6 USD
5% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Intra-Cellular Therapies Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for ITCI is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

ITCI Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one ITCI stock?

The intrinsic value of one ITCI stock under the Base Case scenario is 90.4 USD.

Is ITCI stock undervalued or overvalued?

Compared to the current market price of 131.87 USD, Intra-Cellular Therapies Inc is Overvalued by 31%.

Back to Top